Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Sell
39
ARAY Quote, Financials, Valuation and Earnings
Last price:
$1.84
Seasonality move
:
7.9%
Day range:
$1.78 - $1.89
52-week range:
$1.40 - $3.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.41x
P/B ratio:
4.10x
Volume:
699.6K
Avg. volume:
655.2K
1-year change:
-33.63%
Market cap:
$185.5M
Revenue:
$446.6M
EPS (TTM):
-$0.17
Analysts' Opinion
-
Consensus RatingAccuray has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Accuray has an estimated upside of 231.98% from its current price of $1.85.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $1.85.
Fair Value
-
According to the consensus of 0 analysts, Accuray has 231.98% upside to fair value with a price target of -- per share.
ARAY vs. S&P 500
-
Over the past 5 trading days, Accuray has underperformed the S&P 500 by -1.96% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Accuray does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Accuray revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Accuray reported revenues of $101.5M.
Earnings Growth
-
Accuray earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Accuray reported earnings per share of -$0.04.
Enterprise value:
296.6M
EV / Invested capital:
1.38x
Price / LTM sales:
0.41x
EV / EBIT:
--
EV / Revenue:
0.67x
PEG ratio (5yr expected):
-0.08x
EV / Free cash flow:
-20.83x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
80.96x
Gross Profit (TTM):
$137.9M
Return On Assets:
-3.51%
Net Income Margin (TTM):
-3.72%
Return On Equity:
-35.94%
Return On Invested Capital:
-7.54%
Operating Margin:
-2.12%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $419M | $455M | $444.2M | $103.9M | $101.5M | |
| Gross Profit | $155M | $158.9M | $137.9M | $39.5M | $34.5M | |
| Operating Income | $3.6M | $6.8M | -$3.9M | $2.2M | -$2.1M | |
| EBITDA | $7.1M | $13.2M | $3.7M | $3.1M | $1.1M | |
| Diluted EPS | -$0.11 | -$0.07 | -$0.17 | -$0.03 | -$0.04 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $332.5M | $350.5M | $335.3M | $334.1M | $329.5M | |
| Total Assets | $464.7M | $475.8M | $466.3M | $476.8M | $473.1M | |
| Current Liabilities | $169.1M | $188.3M | $192.5M | $201.4M | $201.8M | |
| Total Liabilities | $397.3M | $430M | $419.4M | $425.9M | $427.9M | |
| Total Equity | $67.4M | $45.8M | $47M | $50.9M | $45.2M | |
| Total Debt | $179.7M | $197.8M | $176.3M | $176M | $170.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $6.2M | $6.9M | -$10.6M | -$8.6M | -$7.3M | |
| Cash From Investing | -$4.5M | -$12.5M | -$3.6M | -$1.1M | -$1.1M | |
| Cash From Financing | -$18.7M | $753K | -$4.6M | -$1.5M | -$2.2M | |
| Free Cash Flow | $1.7M | -$5.6M | -$14.2M | -$9.7M | -$8.4M | |
ARAY
Sector
Market Cap
$185.5M
$44.6M
Price % of 52-Week High
60.49%
45.71%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.68%
1-Year Price Total Return
-33.63%
-29.09%
Beta (5-Year)
1.441
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$1.89
200-day SMA
Sell
Level
$1.96
Bollinger Bands (100)
Sell
Level
1.69 - 2.13
Chaikin Money Flow
Buy
Level
41.2M
20-day SMA
Sell
Level
$1.99
Relative Strength Index (RSI14)
Sell
Level
44.72
ADX Line
Buy
Level
7.14
Williams %R
Neutral
Level
-75.4522
50-day SMA
Sell
Level
$1.90
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
15.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.009)
Sell
CA Score
(Annual)
Level (-1.9143)
Buy
Beneish M-Score
(Annual)
Level (-2.2664)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (2.9594)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
Stock Forecast FAQ
In the current month, ARAY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ARAY average analyst price target in the past 3 months is --.
-
Where Will Accuray Stock Be In 1 Year?
According to analysts, the consensus estimate is that Accuray share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Accuray?
Analysts are divided on their view about Accuray share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Accuray is a Sell and believe this share price will drop from its current level to --.
-
What Is Accuray's Price Target?
The price target for Accuray over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ARAY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Accuray is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ARAY?
You can purchase shares of Accuray via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Accuray shares.
-
What Is The Accuray Share Price Today?
Accuray was last trading at $1.84 per share. This represents the most recent stock quote for Accuray. Yesterday, Accuray closed at $1.85 per share.
-
How To Buy Accuray Stock Online?
In order to purchase Accuray stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Lucid vs Rivian Stock: Which Is Best?
Few realize that Lucid Group (NASDAQ: LCID) traces part of…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
